July 22nd 2024
New research published in Nature Scientific Reports revealed that people with MS are more prone to experience a short-term reduction in disability and brain lesion volume after receiving stem cell therapy.
Study Finding: Discontinuation of Natalizumab for Pregnancy Carries Risk of Disability
February 3rd 2022German research team finds that 11% of those who quit the drug for pregnancy had “clinically meaningful disability” one-year postpartum. They don’t advise against quitting the drug but say their findings suggest that patients should be informed of the risk.
Read More
Thomas P. Leist, MD, PhD, a neurologist and professor of Multiple Sclerosis at Jefferson University Hospitals, is the latest guest featured on MHE Talks: Improving Patient Access podcast. In this episode, Thomas spoke with Peter Wehrwein, senior editor of Managed Healthcare Executive, about accessing care amongst patients with MS through therapies, health insurance barriers, options of step therapy and more.
Read More
Adherence to Disease-Modifying Therapies in Pregnant MS Patients Can Reduce Hospitalization
March 2nd 2021Results from research analyzing data of females with multiple sclerosis (MS) who became pregnant, and the impact of adherence to their disease-modifying therapies (DMTs) on hospital utilization and cost, were recently released by AllianceRx Walgreens Prime.
Read More
Cannabis Extract Treatment for MS Spasticity, Sativex, Opens in US for Phase 3 Trial
November 6th 2020A Phase 3 trial is in the works in the U.S. for Sativex (nabiximols), an oral spray that contains cannabis extracts, in treating spasticity — muscle stiffness or spasms — associated with multiple sclerosis (MS).
Read More
Prospective Study Identifies Factors Associated With Unemployment Among People With MS
October 25th 2020People with MS who are at risk for joblessness have poorer health-related habits and lower “locus of control” scores, according to findings by Kessler Foundation researcher Lauren Strober.
Read More
Similar Cancer Risk Between Patients With MS, General Population in the UK, Study Finds
October 23rd 2020Study found that while frequency of cancer among people with multiple sclerosis (MS) increased over time, the overall cancer risk is similar between patients with MS and the general population.
Read More
In Secondary-Progressive Multiple Sclerosis, Questions Abound, But So Do Breakthroughs
June 4th 2020Much remains unknown about how precisely multiple sclerosis occurs and advances in patients, but a growing body of research is helping scientists develop new ways to slow, and potentially stop, disease progression.
Read More